Daiwa Securities Group’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3K Hold
152
﹤0.01% 1189
2025
Q1
$3K Hold
152
﹤0.01% 1161
2024
Q4
$3K Hold
152
﹤0.01% 1190
2024
Q3
$4K Hold
152
﹤0.01% 1182
2024
Q2
$4K Hold
152
﹤0.01% 1204
2024
Q1
$3K Buy
+152
New +$3K ﹤0.01% 1229